According to filings with the U.S. Securities and Exchange Commission, Patient is raising $3,340,496.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Andrew Heuerman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Patient
Through the development and commercialization of new medical devices and products, The Patient Company aims to redefine what a medical device/product provider should be. The Patient Company is dedicated and focused on improving quality, clinical safety, and employee satisfaction, understanding that these goals are all centered around one clear task: providing clinical staff members with superior tools to better take care of their patients. By bringing together nurses, physicians, administrators, marketers, entrepreneurs and engineers we are able to see healthcare uniquely, solving problems with a We Can All Win mentality that can be felt through the products that we provide. With our first device, SimPull, The Patient Company has perfected lateral patient transfer. By reducing the minimum staff members needed for lateral patient transfer from four to one, staff can remain uninjured, patients can be transferred safely and respectfully, and workflow can be improved. With SimPull, one clinician is able to set up the device, and perform lateral transfer in 2 minutes or less. (SimPull is not yet approved for sale by the FDA.).

To learn more about Patient, visit http://betterpatienttransfers.com/

Contact:
Andrew Heuerman, Chief Executive Officer
602-767-4867
https://www.linkedin.com/in/andrew-heuerman/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.